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Abstract Growing evidence suggests that drug and
alcohol use are fueling the heterosexual transmission of
HIV among African Americans. This study aims to
examine the relative contribution of drug and alcohol use
of male and female partners to risks of heterosexual
transmission of HIV among 535 African American HIV
serodiscordant couples (N = 1,070 participants) who par-
ticipated in an HIV prevention trial. Associations found
between use of drugs and alcohol by one or both partners
and sexual risk indicators varied by type of substance and
whether male or female partner or both partners reported
use. The findings suggest multiple ways in which substance
use of male and female partners may be contributing to the
heterosexual transmission of HIV and other STDs among
African Americans and underscore the need for HIV pre-
vention strategies to address dyadic patterns of substance
use that lead to sexual risks.
The NIMH Multisite HIV/STD Prevention Trial for African
American Couples Study Group
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Introduction
The epidemic of HIV among African Americans in the
United States has continued unabated. African Americans
or blacks represented 51% of all HIV/AIDS cases even
though they represented less than 13% of the U.S. popu-
lation in 2006 [1]. Estimated HIV/AIDS diagnosis rates
among African American men were 7 times higher than for
white men; rates for African American women were 20
times higher than rates than for white women [1]. Two
features distinguish the epidemic in black Americans: the
high rate of infection in women and the high proportion of
HIV cases attributed to heterosexual transmission; both are
also characteristic of the epidemic in Africa. From 2001 to
2005, CDC surveillance data indicate that almost one-
quarter (24%) of HIV positive African American men were
infected by heterosexual contact compared to 6% of white
men, while 80% of African American women were infec-
ted through heterosexual contact compared to 53% of white
women [1]. Growing evidence suggests that drug and
alcohol use may be fueling the heterosexual transmission
of HIV among African American men and women. To
date, however, few studies have examined how the drug
and alcohol use patterns of male and female partners
contribute to sexual risk behaviors that result in HIV
infection among African American heterosexual couples.
Understanding the role of alcohol and various drugs in
contributing to male and female partners’ individual and
shared sexual risk behaviors among African American HIV
serodiscordant couples may inform the design of more
effective prevention strategies to stem the epidemic among
African Americans. Accumulating research over the past
two decades has found that drug and alcohol use are asso-
ciated with having unprotected sex, having concurrent sex-
ual partners, and contracting HIV and other sexually
transmitted diseases (STDs) among African American men
and women [2–5]. This research, however, suggests that
these associations vary substantially by type of substance
use. Unclear, however, is the extent to which the use of
different drugs and alcohol by the male partner, by the female
partner or by both partners may contribute to inconsistent
condom use, sex with outside partners and other sexual risks
that may increase the likelihood of HIV and STD acquisition.
Substantial evidence indicates alcohol use and binge
drinking are consistent predictors of having sex with
multiple partners [4, 6, 7], not using condoms [7] and
testing positive for HIV or STDs [4] in several populations,
including African Americans. Binge drinking was found
to be associated with engaging in sex with multiple con-
current partners in a study of 206 African American HIV
positive men and women [6]. In a recent study of 672
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heterosexual African American men, binge drinking was
associated with having unprotected sex, sex trading and
recent HIV/STD diagnosis [4]. While these studies suggest
that alcohol use indicators are associated with a range of
sexual risk behaviors among both men and women, the
effect of different couple drinking patterns (i.e. whether
one or both partners use alcohol) on sexual risk behaviors
has not yet been adequately researched.
Crack cocaine use has also been identified as impor-
tantly contributing to the disproportionately high rates of
HIV infection and other STDs among heterosexual African
Americans [2, 3, 8]. Substantial evidence indicates that
crack cocaine use among African Americans and mixed
populations increases the likelihood of a range of sexual
risk behaviors, including having unprotected sex [8, 9],
having multiple partners [3, 5], and exchanging sex for
money or drugs [10, 11]. Crack cocaine use is also asso-
ciated with a higher incidence of testing positive for HIV
among heterosexual African Americans [2, 12, 13].
Research findings on the relationship between use of
illicit drugs other than crack cocaine and sexual risks are
sparser and have not focused specifically on African
Americans. Studies of injecting drug users (IDUs) have
found low rates of condom use, high rates of having multiple
sexual partners and high rates of STDs [14–16], suggesting
that sexual transmission may be accounting for a substantial
portion of HIV incidence among IDUs. Some evidence also
has linked non-injection opiate use to inconsistent condom
use, multiple sexual partners and STDs [14–16]; however,
other studies have found no significant associations between
non-injection opiate use and condom use or having multiple
sexual partners [17]. Although several studies have found
that marijuana use increases the likelihood of inconsistent
condom use, multiple sexual partners, and STDs among
adolescents [18–20], few studies have examined the rela-
tionship between marijuana use and sexual HIV risk
behaviors and STDs among adults.
This study aims to address some of the gaps in the
research. We examined the effect of use of alcohol and drugs
on a range of sexual risk behaviors and biological preva-
lence of STDs in a sample of 535 African American HIV
serodiscordant couples (N = 1070). By using couple-level
data from both male and female partners on patterns of
different types of substance use and sexual risk behaviors
and biologically confirmed STDs, this study aims to
examine the relative contribution of the drug and alcohol
use of male and female partners to the risk of HIV/STD
transmission in heterosexual African American HIV sero-
discordant couples. By differentiating drug use by type and
severity of use for both partners and using multiple sexual
risk indicators, this study seeks to advance a more nuanced
understanding of the relative contribution of both partners’
substance use to HIV/STD transmission risks. The specific
purpose of this study is twofold: (1) to describe the preva-
lence of use of different drugs and alcohol, sexual HIV risk
behaviors, and biologically confirmed STDs (i.e., Chla-
mydia, gonorrhea, and trichomoniasis) among African
American HIV serodiscordant couples; and (2) to examine
the multivariate associations between the use of alcohol and
various drugs by male and female partners and three out-
comes: frequency of condom use, having sex with outside
partners, and biological STD prevalence, adjusting for the
sociodemographics of the couples.
Methods
Study Design
This article used baseline data from the Eban study, a two-
arm, couples-based randomized controlled intervention
trial of HIV serodiscordant African-American couples from
four cities in the U.S. (Atlanta, GA, Los Angeles, CA, New
York, NY, and Philadelphia, PA). The study tested the
efficacy of a couple-focused HIV/STD risk reduction
intervention versus an individual-focused health promotion
intervention in reducing sexual risk behaviors and STD
incidence [21]. The study design and details are described
in the NIMH Multisite HIV/STD Prevention Trial [22] in
this issue. For more detail on study design, see also Bel-
lamy et al. [23] and NIMH Multisite HIV/STD Prevention
Trial for African American Couples Group [21].
The Study Sample and Recruitment of the Couples
The study includes 535 couples (1,070 individuals) enrol-
led at four different urban study sites in the U.S.—Atlanta,
Los Angeles, New York and Philadelphia. Couples at all
four sites were recruited from HIV care clinics, HIV testing
and counseling sites, primary care clinics, AIDS services
organizations, substance abuse treatment programs, chur-
ches and HIV/AIDS ministries, HIV/AIDS providers and
community-based coalitions and advocacy organizations.
Study recruitment procedures and eligibility criteria are
described in NIMH Multisite HIV/STD Prevention Trial
[22] in this issue.
Data Collection
Participants completed an Audio Computer-Assisted Survey
Interview (ACASI), which assessed socio-demographics,
relationship characteristics, frequency of use of different
The NIMH Multisite HIV/STD Prevention Trial for African
American Couples Group
Bethesda, MD, USA
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drugs in the past 90 days, drug dependency, alcohol
dependency, and sexual behaviors. Males provided a urine
specimen and women provided two self-obtained vaginal
swab specimens that were assayed for three STDs (chla-
mydia, gonorrhea, and trichomonas). The data summarized
in this article were obtained exclusively from ACASI and
from biologically confirmed STDs.
Assessment of Self-Report Measures
The socio-demographic and sexual behavior measures are
described in detail in NIMH Multisite HIV/STD Prevention
Trial [22] in this issue. The Cutting down, Annoyance by
criticism, Guilty feeling and Eye-openers (CAGE) brief
screener was used to assess lifetime alcohol dependence
[24] and the Texas Christian Drug Screen II (TCUDS) [25]
to identify individuals with a history of heavy drug use and
dependence. Alcohol and drug problems were denoted by
CAGE scores greater than or equal to 2 and by TCUDS
scores greater than or equal to 3, respectively.
Statistical Analysis Methods
Descriptive summaries were calculated for sociodemo-
graphic characteristics and sexual behaviors, and appro-
priate paired two-sample methods were employed to
compare male and female participants. Table 1 presents
means and standard deviations for continuous measures,
with paired t-tests and the resulting P-values comparing
mean male and female measures. Similarly, categorical
measures are summarized by frequencies and percents and
corresponding Cochran–Mantel–Hansel (v2CMH) chi-
squared tests with appropriate degrees of freedom com-
paring the distribution of those frequencies in men and
women. Table 2 summarizes the couple distributions of all
substance use variables of interest. Additionally, this table
presents the average Cochran-Mantel-Hansel estimated
odds ratio (OR), 95% confidence interval (CI) and associ-
ated p-value from testing the null hypothesis that if one and
only one partner in a couple is alcohol- or drug-dependent,
the probability that it is the male equals the probability that
it is the female.
Table 3 presents estimated ORs and corresponding 95%
CIs resulting from logistic regression modeling of each
binary outcome (proportion condom-protected sex, pres-
ence of STDs, and concurrent sexual partners) versus
couple response (whether both partners reported ‘yes’ for
the outcome, the male only reported ‘yes’, the female only
reported ‘yes’, or neither partner reported ‘yes’ [the ref-
erence group]) for various substance-use measures. Simi-
larly, ordinary linear regression was used to estimate mean
differences and corresponding 95% CIs for the log-fre-
quency of unprotected sexual episodes with study partner
in the past 90 days versus the drug and alcohol outcomes of
interest. If participants reported no unprotected sexual
episodes with their partners in the past 90 days, we
imputed 0.01 for those responses so they would be repre-
sented in the fitted model. Finally, adjusted models were
also fit, modeling each outcome versus each substance
abuse measure, adjusting for the following couple-level
variables: gender of the HIV positive partner; the couple’s
age difference, (male partner’s age–female partner’s age),
relationship length, marital status, employment status and
whether both partners were African American.
Because unadjusted and adjusted analyses were similar,
we only report the adjusted analyses (adjusted for gender of
HIV positive partner, couple age difference, relationship
length, marital status, employment status, and whether both
partners were African American) in the text; however, both
unadjusted and adjusted analyses are presented in Table 3.




Table 1 summarizes baseline sociodemographics, rela-
tionship characteristics, alcohol and drug dependency
characteristics of the sample. Additionally, this table
summarizes the sexual risk behaviors (proportion of con-
dom-protected sex, frequency of unprotected sex, preva-
lence of concurrent sexual partners), and prevalence of
STDs. Participants were on average in their low to mid-
forties, a little more than a one-quarter were employed
(28.4%), 71.0% were earning less than $850 per month,
and nearly a third (30.7%) did not have a high school
degree. Compared with male partners, females were sig-
nificantly younger (mean age 41.7 (sd = 7.68) vs. 45.09
(sd = 8.13); paired t = 9.95, P \ 0.0001), less likely to be
employed (22.8 vs. 34.1%, v2CMH ¼ 19:89; P \ 0.0001),
reported significantly shorter times being in a relationship
with their study partners (mean years 6.74 (sd = 6.44) vs.
7.09 (sd = 6.68); paired t = 3.22, p = 0.0014), more
likely to have health insurance (81.9 vs. 68.9%, v2CMH ¼
25:98; P \ 0.0001), and less likely to have been incar-
cerated (48.5 vs. 76.4%, v2CMH ¼ 90:24; P \ 0.0001).
Female participants were significantly less likely to
score positive for alcohol dependency (CAGE C 2) than
were their male partners (13.15 vs. 19.02%, v2CMH ¼ 7:57;
P = 0.0059), however there were no gender of partner
differences in drug dependency (TCUDS C 3; 15.31% vs.
19.09% for females and males, respectively; v2CMH ¼ 3:33;
P = 0.07). The average proportion of condom-protected
sex was 0.44 (sd = 0.43); however, female participants
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Table 1 Demographic characteristics of study population
Males (n = 535) Females (n = 535) Total (N = 1,070) Statistic
Age 45.09 ± 8.13 41.73 ± 7.68 43.41 ± 8.08 9.95****
Education 15.38***
\HS graduate 141 (26.55%) 185 (34.77%) 326 (30.67%)
HS graduate/GED 249 (46.89%) 188 (35.34%) 437 (41.11%)
Some college 141 (26.55%) 159 (29.89%) 300 (28.22%)
Employed 181 (34.09%) 121 (22.83%) 302 (28.4%) 19.89****
Income 3.47
\$400/month 158 (29.81%) 149 (28.11%) 307(28.96%)
$400–850/month 212 (40.00%) 234 (44.15%) 446 (42.08%)
$851–1,650/month 103 (19.43%) 102 (19.25%) 205 (19.34%)
$1,651?/month 57 (10.75%) 45 (8.49%) 102 (9.63%)
Insured 365 (68.87%) 435 (81.92%) 800 (75.40%) 25.98****
Years lived in U.S. 44.25 ± 9.73 40.31 ± 10.01 42.29 ± 9.89 8.18****
Living arrangement 0.96
My own/family home/Apt 446 (83.99%) 452 (84.96%) 898 (84.48%)
Someone else/not family 24 (4.52%) 25 (4.70%) 49 (4.61%)
Rooming/welfare resident 59 (11.11%) 52 (9.77%) 111 (10.44%)
Homeless 2 (0.38%) 3 (0.56%) 5 (0.47%)
Living with study partner 405 (76.42%) 401 (75.52%) 806 (75.97%) 0.71
Time with study partner 7.09 ± 6.68 6.74 ± 6.44 6.91 ± 6.56 3.22**
Married to study partner 175 (32.97%) 170 (32.02%) 345 (32.49%) 0.95
Previously incarcerated 405 (76.42%) 256 (48.48%) 661 (62.45%) 90.24****
Alcohol dependency (CAGE C 2) 101 (19.02%) 70 (13.15%) 171 (16.10%) 7.57**
Drug dependency (TCUDS C 3) 101 (19.09%) 81 (15.31%) 192 (17.20%) 3.33?
Outcomes of interest
Proportion condom-protected sex 0.46 ± 0.43 0.42 ± 0.43 0.44 ± 0.43 3.14**
Unprotected Sex 14.57 ± 25.25 16.57 ± 35.36 15.57 ± 30.71 -1.26
Any STD 28 (5.27%) 120 (22.51%) 148 (13.91%) 75.60****
Concurrent sexual partner 56 (10.59%) 52 (9.77%) 108 (10.18%) 0.29
Values shown are N (%) or mean ± stddev. P-values for continuous variables were determined by paired t-tests; pvaluesfor categorical variables
were determined by CMH tests
? P \ 0.10; * P \ 0.05; ** P \ 0.01; *** P \ 0.001; **** P \ 0.0001
Table 2 Alcohol and drug dependency and use of different substances among both partners, male partner only and female partner only
(N = 535 couples)
Frequency (%) Neither Female only Male only Both ORCMH
(95% CI)
Alcohol dependency 379 (71.78%) 48(9.09%) 79(14.96%) 22(4.17%) 1.65(1.15, 2.36)**
Drug dependency 374(71.37%) 50(9.54%) 70(13.36%) 30(5.73%) 1.40(0.97, 2.01)?
Substance use in the past 90 days
Used any substances to get high or relax 240(45.80%) 60(11.45%) 119(22.71%) 105(20.04%) 1.98(1.45, 2.71)****
Smoked marijuana 318(61.15%) 56(10.77%) 92(17.69%) 54(10.38%) 1.64(1.18, 2.29)**
Injected heroin, cocaine or any other drugs 480(92.84%) 11(2.13%) 21(4.06%) 5(0.97%) 1.91(0.92, 3.96)?
Used any other illegal drugs 337(65.31%) 50(9.69%) 78(15.12%) 51(9.88%) 1.56(1.09, 2.23)*
Odds ratios for males only versus females only (OR), confidence intervals (CI) and P-values are from the Cochran–Mantel–Haenszel (CMH) chi-
square test for categorical variables
? P \ 0.10, * P \ 0.05, ** P \ 0.01, *** P \ 0.001, **** P \ 0.0001
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reported significantly lower proportions than their male
partners (0.42 (sd = 0.43) vs. 0.46 (sd = 0.43), paired
t = 3.14; p = 0.0018). The prevalence of STDs was sig-
nificantly higher in females than in males (22.51 vs. 5.27%,
v2CMH ¼ 75:60; P \ 0.0001). There were no gender-of-
partner differences in reported frequency of unprotected
sex or prevalence of concurrent sexual partners.
Substance Use
Table 2 presents cross classification summaries of each
binary substance abuse variable (e.g., drug dependency,
alcohol dependency, any drug use in the past 90 days,
sniffed or smoked heroin in the past 90 days, smoked
marijuana in the past 90 days, injected drugs in the past
90 days, or used any other illicit drug in the past 90 days)
with the 4 level variable characterizing the gender of the
affected partner (e.g., neither partner affected, female part-
ner only affected, male partner only affected, or both part-
ners affected). Additionally, average ORCMH, 95% CI and
corresponding p-values are also presented to address the
hypothesis that if one and only one partner in a couple is
alcohol- or drug-dependent, the probability that it is the male
equals the probability that it is the female. There were no
gender-of-partner differences in the prevalence of injection
drug use (ORCMH = 1.91, 95% CI: 0.92, 3.96) or drug
dependency (ORCMH = 1.40, 95% CI: 0.97, 2.01). How-
ever, male partners were significantly more likely than
female partners to be the only one in the couple who was
alcohol dependent (ORCMH = 1.65, 95% CI: 1.15, 2.36), to
have used drugs in the past 90 days to get high or to relax
(ORCMH = 1.98, 95% CI: 1.45, 2.71), to have sniffed or
smoked heroin (ORCMH = 2.00, 95% CI: 1.00, 4.00), to
have smoked marijuana in the past 90 days (ORCMH = 1.64,
95% CI: 1.18, 2.29), or to have used some other illicit drug
in the past 90 days (ORCMH = 1.56, 95% CI: 1.09, 2.23).
Table 3 summarizes the results from fitted regression
models which examine the associations between different
substance use variables and four sexual risk outcomes: (1)
condom-protected sex, (2) (log) frequency of unprotected
sexual episodes with study partner in the past 90 days, (3)
presence of an STD, and (4) at least one concurrent sexual
partner. The adjusted models include the following
covariates: gender of HIV positive partner, couple age
difference, relationship length, marital status, employment
status, and whether both partners were African American.
Alcohol Dependency and Sexual HIV Risks
There were no observed differences in likelihood of con-
dom-protected sex, frequency of unprotected sex or prev-
alence of STDs based on which partner(s) if any, in a
couple had alcohol dependency. However, couples where
the female partner (only) scored positive for alcohol
dependency were more likely to report concurrent sexual
partners than couples where neither partner scored positive
for alcohol dependence (OR = 2.53; 95% CI: 1.27, 5.06).
Drug Dependency and Sexual HIV Risks
Couples where both partners scored positive for drug
dependence had approximately 3.56 more unprotected
sexual episodes in the past 90 days, compared with couples
where neither partner was drug dependent ({log} unpro-
tected sex D = 1.27; 95% CI: 0.45, 2.09). Couples where
only the female partner or only the male partner was drug
dependent were more likely to test positive for an STD,
compared with couples where neither partner was drug
dependent (AOR = 2.13; 95% CI: 1.09, 4.16, and
AOR = 2.57; 95% CI: 1.41, 4.69, respectively). Couples
where only the female partner or where both partners were
drug dependent were more likely to report concurrent
sexual partners compared with couples where neither
partner scored positive for drug dependency (AOR = 1.99;
95% CI: 1.00, 3.96, and OR = 3.73; 95% CI: 1.63, 8.58,
respectively).
Use of any Substance to Get High/Relax and Sexual
HIV Risks
Couples’ reported use of any substance to get high or relax
in the past 90 days was associated with increased STD
prevalence. Couples where the female partner only, the
male partner only, or both partners reported such substance
use in the past 90 days were more likely to be STD posi-
tive, compared with couples where neither partner reported
drug use (AOR = 2.86; 95% CI: 1.39, 5.87, AOR = 1.75;
95% CI: 1.02, 3.00, and AOR = 2.18; 95% CI: 1.28, 3.72,
respectively). Couples where only the female partner
reported substance use in the past 90 days were more likely
to report concurrent sexual partners than couples where
neither partner reported substance use in the past 90 days
(AOR = 2.18; 95% CI: 1.01, 4.72). Compared with cou-
ples where neither partner reported using substances to get
high or to relax in the past 90 days, couples where both
partners reported substance use had 2.39 more unprotected
sexual episodes ({log} unprotected sex D = 0.87; 95% CI:
0.29, 1.46).
Marijuana Use and Sexual HIV Risks
Couples where both partners reported marijuana use in the
past 90 days had approximately 3.06 more unprotected
sexual episodes than did couples where neither partner
reported marijuana use ((log) unprotected sex D = 1.12;
95% CI: 0.40, 1.83). Couples where both partners reported
AIDS Behav (2010) 14:1045–1054 1051
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marijuana use were more likely to test positive for an STD
than were couples where neither partner reported marijuana
use (AOR = 2.86; 95% CI: 1.61, 5.06), and couples where
only female partners reported using marijuana were more
likely to have concurrent sexual partners (AOR = 2.77;
CI: 1.42, 5.40).
Injection Drug Use and Sexual HIV risks
Because there were so few couples (\1%) where both
partners reported injection drug use, this group was
excluded from regression analyses. Couples where females
were the only partner to report injection drug use had an
average of 4.66 more unprotected sexual episodes than
couples where neither partner reported use ({log} unpro-
tected sex D = 1.54; 95% CI: 0.76, 2.32).
Use of Other Illicit Drugs and Sexual HIV Risks
Couples where female partners reported using other illicit
drugs (not including marijuana or injection drug use) in the
past 90 days were more likely to have protected sex
(OR = 2.33, 95% CI: 1.31, 4.16); couples where both
partners reported using other drugs reported an average of
2.27 more unprotected sexual episodes ((log) unprotected
sex D = 0.82; 95% CI: 0.08, 1.55); and couples where only
male partners reported other illicit drug use were more
likely to test positive for STDs (OR = 1.84, 95% CI: 1.03,
3.29) than couples where neither partner reported other
illicit drug use. There were no other observed differences.
Discussion
This study found multiple associations between use of
various drugs and alcohol among both partners and a range
of sexual HIV risks, including biologically confirmed
STDs, among this sample of 535 African American HIV
serodiscordant heterosexual couples. These associations
varied by type and severity of substance use and type of
sexual risk indicator and whether the female partner only,
male partner only or both reported substance use. Findings
from this study extend previous research on the relative
contribution of the female partner’s and male partner’s use
of different drugs and alcohol to increasing the likelihood
of sexual risks and STDS among African American HIV
serodiscordant couples.
Both the male and female partner’s drug dependency
increased the likelihood of testing positive for an STD.
Drug dependency by the female partner only also increased
the likelihood of reporting concurrent sexual partners and
reporting a greater number of unprotected sexual episodes.
Similarly, self-report of any substance use to get high or
relax in the past 90 days by female partner only, male
partner only and both partners increased the likelihood of
testing positive for an STD. Any substance use by the
female partner only was also associated with self-report of
having concurrent sexual partners and any substance use by
both partners was associated with a greater number of
unprotected acts of sexual episodes. Contrary to findings
from some previous studies [4, 6, 7], alcohol dependency
by one or both partners was not associated with testing
positive for STDs or self-reported sexual risk indicators
except that female alcohol dependency increased the like-
lihood of concurrent sexual partners. These findings sug-
gest that substance use in general, and drug dependency in
particular, may increase the likelihood of HIV transmission
among HIV serodiscordant couples who report substance
use as they are more likely to engage in unprotected sex
and more likely to test positive for an STD. Testing posi-
tive for an STD not only serves as a biological proxy
indicator for HIV risk but the presence of an STD may also
facilitate the transmission of HIV through open lesions and
sores.
Self-reported marijuana use by either or both partners
was linked to a range of sexual risk indicators, consistent
with previous findings from studies of adolescents [18–20].
Marijuana use by both partners was associated with
reporting a higher number of unprotected sexual acts and
testing positive for an STD. Marijuana use by female
partners increased the likelihood of concurrent sexual
partners. While the role of marijuana use in contributing to
HIV/STD transmission among adults is not well under-
stood, these results suggest that there are multiple ways in
which marijuana use by both partners or by the female
partner may increase the likelihood of transmission. The
rate of injection drug use was relatively low in this sample
and did not increase the likelihood of HIV/STD transmis-
sion risks with the exception that injection drug use by the
female partner was associated with a greater number of
unprotected sexual acts. Use of other illicit drugs by both
partners was associated with a higher number of unpro-
tected sex acts and use of other illicit drugs by the male
partners increased the likelihood of concurrent sexual
partners. The combination of these findings suggests that
use of other illicit drugs, like crack cocaine, may also
contribute to HIV/STD transmission among this sample of
African American HIV serodiscordant couples.
Several limitations of this study should be acknowl-
edged. Because various drugs and alcohol were often used
in combination, it was not possible to isolate the specific
effects of individual drugs or alcohol on HIV/STD trans-
mission. In addition, there was no separate indicator for
crack cocaine use (crack cocaine use was included in
‘‘other illicit drug use’’), which has been found to be
associated with a range of sexual risk behaviors and HIV/
1052 AIDS Behav (2010) 14:1045–1054
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STDs [2, 12, 13]. Second, the study was not able to account
for a broader range of psychosocial covariates that may
have influenced the relationship between substance use and
HIV risk indicators. Third, because this is not a random
sample and because there may be selection bias, there are
limits to the generalizability of these study findings.
Finally, the inability to establish temporal sequencing
between substance use and sexual risk indicators in this
cross-sectional sample limits our ability to interpret study
findings. These limitations should be addressed in future
research.
In spite of these limitations, this study represents several
methodological improvements over previous studies by: (1)
examining a range of self-reported sexual risk indicators
and biologically confirmed prevalence of three different
common STDs; (2) collecting self-reported data on sub-
stance use and HIV risks from both partners and using
couple-level risk behavioral indicators and controlling for
couple-level socio-demographics; (3) enrolling African
American HIV serodiscordant couples from four different
urban locations across the U.S.
The study findings have several implications for policy
and programs to prevent HIV/STD transmission among
African American HIV serodiscordant heterosexual cou-
ples. First, the high rates of substance use, particularly
among male partners, and their associations with multiple
sexual risk indicators underscore the need to conduct rou-
tine screening for substance misuse in HIV treatment and
care services and to improve service linkages to appropri-
ate substance abuse treatment programs. More than one-
quarter (28.6%) of the couples indicated that one or both
partners scored positive for drug dependency, and 28.2%
scored positive for alcohol dependency. Reversing drug
and alcohol dependency in both female and male partners
is likely to have numerous health benefits, including low-
ering the risk for HIV/STD transmission and increasing
adherence to HIV medication. Second, the relatively high
rate of biologically confirmed STDs found among this
sample, which is consistent with STD rates in another
recent study of African American drug users [12], also
suggests the need to conduct routine screening for STDs
among HIV positive men and women receiving HIV
treatment and their HIV negative sexual partners. Failure to
detect STDs in these HIV serodiscordant couples is likely
to increase their risk of HIV transmission, as open lesions
and sores from STDs can facilitate the transmission of
HIV. Third, there are multiple contexts in which use of
various drugs and alcohol and substance misuse may
contribute to HIV/STD transmission in HIV serodiscordant
couples, including: having sex with multiple concurrent
partners, having sex under the influence of drugs with
impaired ability and judgment to negotiate safer sex and to
use condoms, trading sex for money or drugs to satisfy
addiction needs and avoid going through withdrawal for
self or partners, and contracting STDs. Finally, the study
findings underscore the need for couple-based HIV pre-
vention interventions that address the different drug-related
triggers for sexual HIV risk behaviors among African
American HIV serodiscordant heterosexual couples. Such
couple-based HIV prevention strategies may synergisti-
cally address dyadic patterns of drug involvement and
substance misuse that lead to inconsistent condom use and
having multiple concurrent sexual partners. In sum, these
study findings build upon previous research that suggests
that drug and alcohol use may be playing a significant role
in the spread of HIV and other STDs among African
Americans. Effective intervention strategies to reduce drug
involvement and substance misuse while addressing co-
occurring HIV risks in this population are urgently needed
in the public health arena. Such strategies may ultimately
help curb the HIV epidemic among African American
heterosexual men and women.
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